Tango Therapeutics, Inc. is Director of Blueprint Medicines Corp. Currently has a direct ownership of 3,400 shares of BPMC, which is worth approximately $293,420. The most recent transaction as insider was on Dec 08, 2021, when has been sold 3,400 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.4K
0% 3M change
0% 12M change
Total Value Held $293,420

Tango Therapeutics, Inc. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 08 2021
BUY
Grant, award, or other acquisition
-
3,400 Added 50.0%
3,400 Common Stock
TTI

Tango Therapeutics, Inc.

Director
Cambridge, MA

Track Institutional and Insider Activities on BPMC

Follow Blueprint Medicines Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BPMC shares.

Notify only if

Insider Trading

Get notified when an Blueprint Medicines Corp insider buys or sells BPMC shares.

Notify only if

News

Receive news related to Blueprint Medicines Corp

Track Activities on BPMC